Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

57.17 +1.74 (+3.14%)

Delayed Quote Updated: 3:42 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

37 38 Next >

3 Profitable CRISPR Stocks Earning Analysts’ Praise ↗

July 09, 2024

Revolutionary gene-editing technologies provide promise for investors seeking the most profitable CRISPR stocks today and in the future.

Via InvestorPlace

7 Growth Stocks to Invest $500 In and Cash Out $100K by 2030 ↗

July 09, 2024

Investing $500 in these seven high-growth stocks could potentially turn into $100,000 by 2030, offering massive upside.

Via InvestorPlace

The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 ↗

July 09, 2024

Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge.

Via InvestorPlace

The 3 Best Gene Editing Stocks to Buy in July 2024 ↗

July 08, 2024

Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks.

Via InvestorPlace

3 Pharma Stocks Already Ushering in the Next Biotech Boom ↗

July 08, 2024

So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider.

Via InvestorPlace

3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow ↗

May 26, 2024

There are a handful of different factors that could buoy its stock.

Via The Motley Fool

Is CRISPR Therapeutics a Millionaire Maker? ↗

May 22, 2024

The stars are aligning for it to be a leader for years to come.

Via The Motley Fool

Is CRISPR Therapeutics Stock a Buy? ↗

May 17, 2024

The gene-editing therapy specialist is rising in prominence.

Via The Motley Fool

3 Top-Rated Gene Editing Stocks Actually Making Money ↗

July 03, 2024

Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond.

Via InvestorPlace

Trading SMID Biotech Stocks In A Volatile Market ↗

July 01, 2024

Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...

Via Talk Markets

You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever. ↗

June 27, 2024

The best gene editing stocks to buy are those with strong tehnogical applications and genuine commercialization prospects.

Via InvestorPlace

Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich ↗

June 27, 2024

These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience.

Via InvestorPlace

You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever. ↗

June 27, 2024

Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions.

Via InvestorPlace

Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued." ↗

June 27, 2024

The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon.

Via The Motley Fool

3 Biotech Stocks That Could Make Your Grandchildren Rich ↗

June 27, 2024

These biotech stocks are poised to generate significant returns to investors due to their high growth potential.

Via InvestorPlace

Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich ↗

June 26, 2024

Gene editing is a game-changer, creating substantial opportunities for some of the leading gene editing stocks.

Via InvestorPlace

3 Gene Editing Stocks That Could Make Your Grandchildren Rich ↗

June 25, 2024

Explore gene-editing stocks with long-term growth potential, offering innovative solutions to previously untreatable conditions.

Via InvestorPlace

The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom ↗

June 24, 2024

These three sleeper stocks could deliver massive gains if their cutting-edge technologies take off in the coming years.

Via InvestorPlace

7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom ↗

June 12, 2024

With so many young people eager to get out of the corporate rat race, these FIRE stocks can accelerate your path and stay free.

Via InvestorPlace

Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought ↗

June 09, 2024

These companies could generate explosive growth over time.

Via The Motley Fool

Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? ↗

June 04, 2024

In keeping with Cathie Wood's style, these picks are riskier than average.

Via The Motley Fool

Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You? ↗

May 31, 2024

Teladoc's share performance has reflected its earnings struggles...

Via The Motley Fool

7 Stocks You Haven’t Heard of (That EVERYONE Should Own) ↗

May 29, 2024

These under-the-radar must-own stocks across various sectors are using powerful megatrends and posting solid financial results.

Via InvestorPlace

7 Biotech Stocks to Put on Your Breakthrough Radar ↗

May 27, 2024

Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance.

Via InvestorPlace

The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now ↗

May 23, 2024

With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy.

Via InvestorPlace

7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition ↗

May 22, 2024

With a modest $1,000 investment, these stocks offer the potential for market-beating gains through solid fundamentals and growth prospects.

Via InvestorPlace

Bull Market Buys: 2 Growth Stocks to Own for the Long Run ↗

May 22, 2024

These biotech stocks have just launched their first products.

Via The Motley Fool

Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗

May 17, 2024

With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.

Via InvestorPlace

7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024 ↗

May 16, 2024

Here are seven stocks to buy and hold that are poised for long-term growth over the next 20 years and can future-proof your portfolio.

Via InvestorPlace

Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. ↗

May 15, 2024

How much would you pay for a stock that might earn $25 a year in six years?

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

37 38 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

All News about CRISPR Therapeutics AG - Common Shares

Starting at /week.